Nicergoline

Nicergoline is a pharmaceutical compound used primarily to treat senile dementia and other vascular-related disorders. It is an ergot derivative that has also been utilized internationally for conditions such as frontotemporal dementia, early onset Lewy body dementia, and Parkinson's dementia, distinguishing itself by its vascular benefits. The primary beneficiaries of Nicergoline are elderly patients suffering from cognitive decline and various forms of dementia with vascular components.

Nicergoline was discovered on May 3rd 2019 and it currently has a search volume of 6.6K with a growth of +200%.